129 related articles for article (PubMed ID: 29137260)
1. Pathologic subtype-defined prognosis is dependent on both tumor stage and status of oncogenic driver mutations in lung adenocarcinoma.
Dong Y; Li Y; Jin B; Zhang J; Shao J; Peng H; Tu S; Han B
Oncotarget; 2017 Oct; 8(47):82244-82255. PubMed ID: 29137260
[TBL] [Abstract][Full Text] [Related]
2. Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose.
Li H; Pan Y; Li Y; Li C; Wang R; Hu H; Zhang Y; Ye T; Wang L; Shen L; Sun Y; Chen H
Lung Cancer; 2013 Jan; 79(1):8-13. PubMed ID: 23098378
[TBL] [Abstract][Full Text] [Related]
3. Targeted Sequencing Analysis of Predominant Histological Subtypes in Resected Stage I Invasive Lung Adenocarcinoma.
Li Y; Tan Y; Hu S; Xie J; Yan Z; Zhang X; Zong Y; Han-Zhang H; Li Q; Li C
J Cancer; 2021; 12(11):3222-3229. PubMed ID: 33976731
[No Abstract] [Full Text] [Related]
4. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma.
Hu H; Pan Y; Li Y; Wang L; Wang R; Zhang Y; Li H; Ye T; Zhang Y; Luo X; Shao L; Sun Z; Cai D; Xu J; Lu Q; Deng Y; Shen L; Ji H; Sun Y; Chen H
Onco Targets Ther; 2014; 7():1423-37. PubMed ID: 25152623
[TBL] [Abstract][Full Text] [Related]
6. Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.
Russell PA; Barnett SA; Walkiewicz M; Wainer Z; Conron M; Wright GM; Gooi J; Knight S; Wynne R; Liew D; John T
J Thorac Oncol; 2013 Apr; 8(4):461-8. PubMed ID: 23486266
[TBL] [Abstract][Full Text] [Related]
7. Analysis of major known driver mutations and prognosis in resected adenosquamous lung carcinomas.
Wang R; Pan Y; Li C; Zhang H; Garfield D; Li Y; Ye T; Hu H; Luo X; Li H; Zhang Y; Zhang J; Zhou X; Shen L; Pao W; Sun Y; Chen H
J Thorac Oncol; 2014 Jun; 9(6):760-8. PubMed ID: 24481316
[TBL] [Abstract][Full Text] [Related]
8. Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patients.
Lu F; Li S; Dong B; Zhang S; Lv C; Yang Y
Thorac Cancer; 2016 Jan; 7(1):17-23. PubMed ID: 26816535
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive study of mutational and clinicopathologic characteristics of adenocarcinoma with lepidic pattern in surgical resected lung adenocarcinoma.
Xu Y; Zhu C; Qian W; Zheng M
J Cancer Res Clin Oncol; 2017 Jan; 143(1):181-186. PubMed ID: 27738759
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive investigation of molecular features and prognosis of lung adenocarcinoma with micropapillary component.
Zhang Y; Wang R; Cai D; Li Y; Pan Y; Hu H; Wang L; Li H; Ye T; Luo X; Zhang Y; Li B; Shen L; Sun Y; Chen H
J Thorac Oncol; 2014 Dec; 9(12):1772-8. PubMed ID: 25226429
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Value of Non-Predominant Micropapillary Pattern in a Large Cohort of Resected Invasive Lung Adenocarcinoma Measuring ≤3 cm.
Zhang H; Huang W; Liu C; Giaccone G; Zhao X; Sun X; Li J; Cheng R; Huang Q; Mo H; Zhang Z; Zhang B; Wang C
Front Oncol; 2021; 11():657506. PubMed ID: 34026636
[TBL] [Abstract][Full Text] [Related]
12. [Impact of Smoking on the Histological Subtype and Outcome of the Primary Lung Adenocarcinoma].
Xu Y; Tan WW; Fan P; Yang ZZ; Zhang S; Xi JL; Wang YX; Hu X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 50(6):867-871. PubMed ID: 31880119
[TBL] [Abstract][Full Text] [Related]
13. Mutations of the EGFR, K-ras, EML4-ALK, and BRAF genes in resected pathological stage I lung adenocarcinoma.
Ohba T; Toyokawa G; Osoegawa A; Hirai F; Yamaguchi M; Taguchi K; Seto T; Takenoyama M; Ichinose Y; Sugio K
Surg Today; 2016 Sep; 46(9):1091-8. PubMed ID: 26711128
[TBL] [Abstract][Full Text] [Related]
14. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H
J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell proliferation (Ki-67) expression and its prognostic significance in histological subtypes of lung adenocarcinoma.
Li Z; Li F; Pan C; He Z; Pan X; Zhu Q; Wu W; Chen L
Lung Cancer; 2021 Apr; 154():69-75. PubMed ID: 33626488
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Clinicopathological Features and Prognosis between
Li P; Gao Q; Jiang X; Zhan Z; Yan Q; Li Z; Huang C
J Cancer; 2019; 10(1):61-71. PubMed ID: 30662526
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum carcinoembryonic antigen levels are associated with histologic subtype, EGFR mutations, and ALK fusion in patients with completely resected lung adenocarcinoma.
Wang Z; Yang S; Lu H
Onco Targets Ther; 2017; 10():3345-3351. PubMed ID: 28744138
[TBL] [Abstract][Full Text] [Related]
18. The presence of lepidic and micropapillary/solid pathological patterns as minor components has prognostic value in patients with intermediate-grade invasive lung adenocarcinoma.
Hou Y; Song W; Chen M; Zhang J; Luo Q; Um SW; Facchinetti F; Bongiolatti S; Zhou Q
Transl Lung Cancer Res; 2022 Jan; 11(1):64-74. PubMed ID: 35242628
[TBL] [Abstract][Full Text] [Related]
19. Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma.
Park J; Kobayashi Y; Urayama KY; Yamaura H; Yatabe Y; Hida T
PLoS One; 2016; 11(8):e0161081. PubMed ID: 27518729
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of the second predominant subtype in lung adenocarcinoma: a retrospective single-center cohort study.
Sun S; Li S; Li J; Li X; Ding Y; Liu X; Wang K; Shi Y; Sun D
J Thorac Dis; 2022 Dec; 14(12):4846-4864. PubMed ID: 36647489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
